These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7164757)

  • 1. [Treatment of metastasizing breast cancer with aminoglutethimide].
    Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
    Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)].
    Rieche K
    Dtsch Med Wochenschr; 1981 Oct; 106(40):1296-300. PubMed ID: 7274074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
    Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aminoglutethimide in the treatment of metastasizing breast carcinoma in old age].
    Gorgone S; Lorenzini C; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Apr; 39(2):166-75. PubMed ID: 3652316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
    Bonneterre J; Pion JM; Demaille A
    Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose aminoglutethimide therapy without cortisol substitution in postmenopause metastasizing breast cancer].
    Höffken K; Miller AA; Miller B; Becher R; Aulbert E; Hoffmann B; Anders CU; Callies R; Schmidt CG
    Med Klin (Munich); 1986 Oct; 81(20):638-42. PubMed ID: 3785061
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical adrenalectomy with aminoglutethimide-cortisol in the treatment of metastatic breast carcinoma.
    Paridaens R; Van Haelen C; Heuson JC
    Eur J Cancer (1965); 1980; Suppl 1():103-6. PubMed ID: 7318860
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.
    Coombes RC; Powles TJ; Easton D; Chilvers C; Ford HT; Smith IE; McKinna A; White H; Bradbeer J; Yarnold J
    Cancer Res; 1987 May; 47(9):2494-7. PubMed ID: 3552216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
    Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
    N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with Rodazol therapy in the treatment of postmenopausal patients with metastatic breast cancer].
    Stier G; Gürtler R; Schmidt UM; Müller U; Tanneberger S
    Zentralbl Gynakol; 1990; 112(17):1101-4. PubMed ID: 2264420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
    Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.